Neuroblastoma Parent Symposium 2026
April 2 @ 19:00 - 20:00
About the symposiums
Following a neuroblastoma diagnosis, children and families face difficult challenges and complex treatment decisions. SKC symposium aims to bring together the neuroblastoma community from across the UK and around the world to share knowledge, insights, and support.
Delivered both in-person and virtually over the years, the symposium offers an accessible space to learn about current approaches, emerging research, and lived experience.
2026 webinar series
The 2026 symposium will take place over six Thursday evenings, from 26 February to 2 April, with each session running from 6:00 – 7:00 pm UK local time (19:00 – 20:00 CET). This year’s programme brings together a variety of topics, including how to find trusted information, what current frontline treatment looks like in the UK, Europe and the US, and the latest developments in clinical trials. You’ll hear from leading neuroblastoma experts and parent advocates, with opportunities to submit questions during every session. The series concludes with an extended session focused on enhancing quality of life after treatment. You can view the full programme here.
When you register, you’ll receive joining links for all six sessions, giving you the flexibility to join as many sessions as you like, plus early access to the webinar recordings. We encourage you to join live whenever possible – taking part together as a community creates a more interactive and supportive experience, and gives you the chance to submit questions and hear answers in real time. When you register, you’ll receive joining links for all six sessions, giving you the flexibility to join as many sessions as you like, plus early access to the webinar recordings. We encourage you to join live whenever possible – taking part together as a community creates a more interactive and supportive experience, and gives you the chance to submit questions and hear answers in real time.
Webinar Series
- Webinar 1 – Thursday, 26 February 2026: Finding Trusted Information: Navigating the Neuroblastoma Journey
- Webinar 2 – Thursday, 5 March 2026: Understanding Current Frontline Treatment: COG and SIOPEN
- Webinar 3 – Thursday, 12 March 2026: BEACON2: Expanding Treatment Options for Relapsed Neuroblastoma
- Webinar 4 – Thursday, 19 March 2026: The MINT Study: Addressing Unmet Need in High‑Risk Neuroblastoma
- Webinar 5 – Thursday, 26 March 2026: CAR‑T Cell Therapy: Bambino Gesù Trial and Broadening Treatment in Europe
- Webinar 6 – Thursday, 2 April 2026: Life After Treatment: Enhancing Quality of Life for Neuroblastoma Families